Here’s Why Medpace (MEDP) Shares Roared in 2025

1 month ago 31

Soumya Eswaran

Fri, January 30, 2026 astatine 8:06 AM CST 3 min read

Giverny Capital Asset Management, LLC, an concern absorption company, precocious published its fourth-quarter 2025 capitalist letter. A transcript of the aforesaid tin beryllium downloaded here. The Portfolio returned 0.01% compared to 2.66% for the S&P 500. YTD, the money returned 12.58% compared to 17.88% for the Index. The steadfast faced a challenging 4th fourth and calendar year, contempt coagulated appreciation. The outperformance of a fewer ample exertion companies has negatively impacted performance, fixed the portfolio's underweight successful ample tech and overweight successful smaller niche leaders. While portfolio companies are excelling successful net maturation and superior returns, the marketplace is fixated connected AI investments, leaving the existent benefits unclear. Additionally, you tin reappraisal the Portfolio’s apical 5 holdings to spot its champion picks for 2025.

In its fourth-quarter 2025 capitalist letter, Giverny Capital Asset Management highlighted Medpace Holdings, Inc. (NASDAQ:MEDP) arsenic 1 of its starring contributors. Medpace Holdings, Inc. (NASDAQ:MEDP) is simply a objective research-based cause and aesculapian instrumentality improvement services provider. The one-month instrumentality of Medpace Holdings, Inc. (NASDAQ:MEDP) was 3.86%, and its shares gained 69.86% of their worth implicit the past 52 weeks. On January 29, 2026, Medpace Holdings, Inc. (NASDAQ:MEDP) banal closed astatine $593.07 per share, with a marketplace capitalization of $16.706 billion.

Giverny Capital Asset Management stated the pursuing regarding Medpace Holdings, Inc. (NASDAQ:MEDP) successful its 4th fourth 2025 capitalist letter:

"Medpace Holdings, Inc. (NASDAQ:MEDP) is simply a objective probe enactment whose banal dipped connected fears that backing for biopharmaceutical cause trials would adust up, and past roared aft the backing did not, successful fact, adust up. Medpace has outstanding absorption and bought backmost astir 9% of its shares earlier successful the twelvemonth erstwhile the banal terms was weaker."

Medpace Holdings, Inc. (NASDAQ:MEDP) is not connected our database of 30 Most Popular Stocks Among Hedge Funds. As per our database, 43 hedge money portfolios held Medpace Holdings, Inc. (NASDAQ:MEDP) astatine the extremity of the 3rd quarter, which was 42 successful the erstwhile quarter. Medpace Holdings, Inc. (NASDAQ:MEDP) reported revenue of $659.9 cardinal successful the 3rd 4th 2025, representing an summation of 23.7% year-over-year. While we admit the imaginable of Medpace Holdings, Inc. (NASDAQ:MEDP) arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.